DFDA

Sumatriptan (subcutaneous)

Treatment for Cluster Headache

Typical Dosage: 6 mg subcutaneous

Effectiveness
90%
Safety Score
68%
Clinical Trials
55
Participants
5.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
68
DangerousModerateSafe
Treatment Details
Dosage Range
6 mg subcutaneous
Time to Effect
5-10 minutes
Treatment Duration
As needed (acute)
Evidence Quality
HIGH
Number Needed to Treat (NNT)
2.5(Treat 2.5 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2,700
Monitoring:$1,000
Side Effect Mgmt:$50
Total Annual:$3,750
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$3,667
Sumatriptan (subcutaneous) Outcomes

for Cluster Headache

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+75%
Common Side Effects
Injection site reaction
+15%
Chest discomfort
+4%
Dizziness
+3%
Nausea
+3%

Sources:

nih.gov
nih.gov
semanticscholar.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov